Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening to Improve Early Diagnosis for Women of All Social and Ethnic Backgrounds

NCT07219277 is registered in ClinicalTrials.gov with Syantra Inc. as lead sponsor.

NCT NCT07219277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07219277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening to Improve Early Diagnosis for Women of All Social and Ethnic Backgrounds
Lead sponsor
Syantra Inc.
Phase
Observational
Overall status
Recruiting
Start date
January 7, 2026
Completion date
June 14, 2027
Enrollment
2,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, liquid biopsy, early detection